PSTV
Plus Therapeutics Inc
NASDAQ: PSTV · HEALTHCARE · BIOTECHNOLOGY
$5.60
-5.88% today
Updated 2026-04-29
Market cap
$40.83M
P/E ratio
—
P/S ratio
7.83x
EPS (TTM)
$-7.25
Dividend yield
—
52W range
$3 – $24
Volume
3.6M
Plus Therapeutics Inc (PSTV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-420.00%
ROE
-522.00%
ROA
-83.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $7.93M | $-25.45M | 79.39% | -326.16% | -321.02% |
| 2007 | $6.05M | $-28.67M | 93.02% | -518.27% | -474.00% |
| 2008 | $6.85M | $-30.04M | 72.95% | -434.28% | -438.29% |
| 2009 | $14.73M | $-23.22M | 76.96% | -146.28% | -157.61% |
| 2010 | $10.63M | $-27.49M | 63.23% | -250.10% | -258.72% |
| 2011 | $10.00M | $-32.45M | 61.61% | -330.45% | -324.64% |
| 2012 | $14.50M | $-32.28M | 72.42% | -195.07% | -222.60% |
| 2013 | $12.20M | $-26.18M | 71.95% | -251.55% | -214.64% |
| 2014 | $7.60M | $-37.37M | 61.31% | -426.91% | -491.81% |
| 2015 | $11.66M | $-18.74M | 72.67% | -131.11% | -160.77% |
| 2016 | $11.38M | $-22.05M | 76.14% | -173.16% | -193.73% |
| 2017 | $6.41M | $-22.69M | 79.44% | -322.62% | -353.86% |
| 2018 | $2.98M | $-12.63M | 61.52% | -293.73% | -423.53% |
| 2019 | $7.00M | $-10.89M | 100.00% | -52.26% | -155.57% |
| 2020 | $303000.00 | $-8.24M | -791.09% | -3,163.04% | -2,719.80% |
| 2021 | $0.00 | $-13.40M | — | — | — |
| 2022 | $224000.00 | $-20.27M | -217.86% | -8,800.00% | -9,051.34% |
| 2023 | $4.91M | $-13.32M | -97.23% | -271.14% | -271.04% |
| 2024 | $5.82M | $-12.98M | 85.37% | -252.32% | -222.84% |
| 2025 | $5.21M | $-22.39M | 91.46% | -293.46% | -429.43% |